AI assistant
Sending…
BRUNSWICK CORP — Director's Dealing 2019
Oct 30, 2019
31141_dirs_2019-10-30_c2e291c9-a6ad-4872-b623-1b1eaa034343.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BRUNSWICK CORP (BC)
CIK: 0000014930
Period of Report: 2019-10-28
Reporting Person: METZGER WILLIAM (SR. VICE PRESIDENT AND CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-28 | Common Stock | M | 11500 | $21.52 | Acquired | 155036 | Direct |
| 2019-10-28 | Common Stock | F | 3269 | $60.07 | Disposed | 151767 | Direct |
| 2019-10-28 | Common Stock | D | 4120 | $60.07 | Disposed | 147647 | Direct |
| 2019-10-29 | Common Stock | S | 4111 | $59.65 | Disposed | 143536 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-10-28 | Stock Settled Stock Appreciation Right | $21.52 | M | 11500 | Disposed | 2021-02-08 | Common Stock (11500.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1170 | Indirect |
Footnotes
F1: Beneficial holdings include 107 shares acquired pursuant to dividend reinvestment in September 2019.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.40 to $59.82 inclusive.
F3: Employee Stock-Settled Stock Appreciation Right granted under the Brunswick Corporation 2003 Stock Incentive Plan.
F4: Currently all shares are exercisable.
More from BRUNSWICK CORP
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 17